Emcure Pharma Establishes Dedicated Subsidiary for Dermatology

Emcure Pharmaceuticals Limited has announced the formation of a wholly-owned subsidiary, Emcutix Biopharmaceuticals Limited, which will focus exclusively on dermatology...

MMV and Quotient begin Clinical Trial for Malaria Prevention Injectable

Medicines for Malaria Venture (MMV) and Quotient Sciences have begun the first clinical trial for a long-acting injectable (LAI) preventive compound for malaria. The trial, conducted in healthy volunteers in Nottingham, UK, marks a significant...

India Poised to Export Over 50% of Pharma Production

In the previous year, approximately half of India’s pharmaceutical and biological products were sent overseas, signaling a significant change towards a pharmaceutical industry focused on exports as India nears exporting over 50% of its output...

Tyra Biosciences Receives FDA Nod for TYRA-300 Phase 2 Trial

Tyra Biosciences, Inc., a biotechnology company in the clinical development stage, revealed that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for TYRA-300, enabling the company to move...

Laborie Secures New AMA CPT Code for Advanced Prostate Procedure

Laborie Medical Technologies Corp (Laborie), a top company in diagnostic and therapeutic medical technology, disclosed that the American Medical Association (AMA) has introduced the new Category 1 Current Procedural Terminology (CPT) code 52XX2...

PM Modi to Introduce Medical Devices and Bulk Drug Facilities

Prime Minister Narendra Modi is set to launch five projects as part of the production linked incentive (PLI) scheme for medical devices and bulk drugs today, during Dhanvantari Jayanti and 9th Ayurveda Day celebrations. He is scheduled to open...

Dr Reddy's Secures CDSCO Nod, Becomes First to Launch Elobixibat in India

Dr Reddy's is the first leading pharmaceutical company to obtain approval from the Central Drugs Standard Control Organisation (CDSCO) to introduce Elobixibat in India. Elobixibat works by preventing bile acids from being reabsorbed in the ileum...

AI Dialysis Machine to transform Renal Care, Cutting Costs by 75%

The AI-powered smart haemodialysis machine aims to increase access to renal care and reduce costs by up to 75%, bringing the price down to approximately Rs 2 lakh. Nephro Care India Limited (NCIL) is working with the National Institute of...

Lyell Immunopharma Acquires ImmPACT Bio to Expand CAR T-Cell Pipeline

Lyell Immunopharma, Inc, located in South San Francisco, revealed that it has finalized a deal to purchase ImmPACT Bio USA Inc, a clinical-stage biotech company, as part of its efforts to develop advanced CAR T-cell therapies for cancer...

Dozee's AI Predicts Health Deterioration 16 Hours Early in Advance

Dozee, India’s Health AI leader, has unveiled the findings of a landmark study published in the internationally renowned journal Frontiers in Medical Technology. This journal is part of the prestigious Frontiers group. The study was conducted at...

© 2024 India Pharma Outlook. All Rights Reserved.